Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07382700

Metabolic Characteristics of Plasma OxPLs in STEMI Patients.

The goal of this observational study is to investigate the structural composition and metabolic characteristics of OxPLs in STEMI patients. Explore OxPLs characteristic fingerprint biomarkers from different populations and analyze OxPLs fingerprint spectra. Based on the OxPLs fingerprint of STEMI patients, a machine learning classifier is used to establish an artificial intelligence assisted post PCI MACE risk prediction system, achieving the transformation of basic research into clinical application.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

STEMI - ST-segment Elevation Myocardial Infarction

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

First Affiliated Hospital of Ningbo University

Ningbo, Zhejiang, 315010, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient meets the diagnostic criteria for STEMI (refer to the "Diagnosis and Treatment Guidelines for Acute ST Segment Elevation Myocardial Infarction (2021)")
  • Agree to perform direct PCI
  • The onset time is less than 12 hours and successfully undergoing emergency PCI treatment
  • After admission, all STEMI patients are routinely treated with antiplatelet aggregation, anticoagulation, lipid-lowering, and anti myocardial remodeling drugs.

Exclusion criteria

  • Previous history of myocardial infarction
  • Accompanied by other cardiovascular diseases, such as severe heart valve disease, severe heart failure, congenital heart disease, cardiomyopathy, etc
  • Merge with severe infection
  • Merge with severe anemia
  • Merge with severe liver and kidney dysfunction
  • Combined with malignant tumors
  • Accompanied by a history of autoimmune or hematological diseases
  • Recent history of severe trauma or surgery
  • Patients with incomplete clinical data
  • The patient does not agree to undergo data collection

Treatment and study plan

Primary outcomes

  1. Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v5.0

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital of Ningbo University

Network

Registry information

Official study title

Metabolic Characteristics of Plasma OxPLs in STEMI Patients and Its Value Analysis in Predicting MACEs Risk After PCI Surgery.

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Feb 3, 2026
Registry last updated
Feb 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.